SUSMED’s DTx Approved in Japan for the Treatment of Insomnia
SUSMED, Inc. (TOKYO:4263) announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (the ”MHLW”) of SUSMED Med CBT-i® App for Insomnia (the ”product”). SUSMED is in the process of applying for insurance coverage, and market launch.
SUSMED, Inc. (TOKYO:4263) announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare (the ”MHLW”) of SUSMED Med CBT-i® App for Insomnia (the ”product”). SUSMED is in the process of applying for insurance coverage, and market launch.